This piece was reprinted by OpEd News with permission or license. It may not be reproduced in any form without permission or license from the source.
When queried whether there had ever been any DoD research on any kind of prisoner, or the use of HHS personnel to monitor such research, a spokesperson for Defense Research and Engineering indicated that they had no comment.
In 2002, there was another assault on prisoner protections for research, when Bush's Secretary of HHS asked for and received a year later a blanket waiver for all informed consent on prisoner experimentation for "epidemiological" reasons, including the taking of biological samples. In a future article, I will explore the repercussions of this new policy -- also never discussed by any ethical panel, and certainly not by the NRC -- on research upon prisoners, and more specifically the possibility of experiments done on the detainees at Guantanamo.
This further investigation may throw light upon the Guantanamo SOP wherein all detainees were subjected to a never-before-attempted use of mass administration of treatment doses of the controversial anti-malaria drug mefloquine (Lariam), as also reported in a special investigation by Jason Leopold and myself last December. The scandal was also the subject of an independent investigatory report published at the same time by Seton Hall University Law School's Center for Policy and Research.
In a 2002 report on mefloquine adverse events, "Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults," published in top medical journal Acta Tropica, it was noted that 73% of the participants suffered "severe (grade 3) vertigo..." which "required bed rest and specific medication for 1 to 4 days." Nevertheless, DoD maintains that the use of mefloquine was for public health purposes, to prevent malaria from spreading in Cuba. But as our investigation showed, talking with military medical experts, and examining other military responses to malaria threat, including in Cuba, no such use of such mass treatment doses, with its attendant dangers, was ever used or even proposed. Nor did DoD medical officers at Guantanamo demand the same protocols be used on foreign workers from malarial areas brought into the camp at this same time to work on building Camp Delta and other facilities at the naval base. The workers were employed by Kellogg Brown and Root, a subsidiary of Halliburton.
Was the mefloquine use part of an experimental protocol on the adverse side effects of the drug, a subject of much controversy within DoD at the time? Was it a method of softening up prisoners for interrogation? While calls for greater transparency go unheeded, further investigation by the press may bring answers to these explosive questions.
Originally posted at Firedoglake
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
1
1
1
